Immunoreactivity and pharmacokinetics of horse anti-scorpion venom F(ab')2-scorpion venom interactions

Toxicology and Applied Pharmacology

Volumn 141, Issue 1, 1996, Pages 272-277

  Pépin Covatta, Stéphanie ^a,c   Lutsch, Charles ^d   Grandgeorge, Michel ^d   Lang, Jean ^b   Scherrmann, Jean Michel ^a  

^a HÔPITAL FERNAND WIDAL   (France)

^b Pasteur Merieux Serums et Vaccins   (France)

^c INSERM   (France)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTITOXIN; SCORPION VENOM; TOXIN ANTIBODY;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; HORSE; IMMUNORADIOMETRIC ASSAY; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; RABBIT; TOXICOKINETICS;

ANIMALIA; BUTHUS; BUTHUS OCCITANUS MARDOCHEI; EQUUS CABALLUS; ORYCTOLAGUS CUNICULUS; SCORPIONES;

EID: 0030297275     PISSN: 0041008X     EISSN: None     Source Type: Journal    
DOI: 10.1006/taap.1996.0284     Document Type: Article

References (25)

1. Altaian, P. L. (1961). Blood and other body fluids. Analysis and compila-tion. Biological Handbooks.
2. Audebert, F., Urtizberea, M., Sabouraud, A., Scherrmann, J. M., and Bon, C. (1994). Pharmacokinetics of Vipera Aspis venom after experimental envenomation in rabbits. /. Pharmacol Exp. Ther. 268, 1512-1517.
3. Bond, G. R. (1992). Antivenin administration for Centruroides scorpion stings: Risks and benefits. Ann. Emerg. Med. 21, 788-791.
4. Butler, V. P., Schmidt, D. H., and Smith, T. W. (1977). Effects of sheep digoxin-specific antibodies and their Fab fragments on digoxin pharmaco-kinetics in dogs. /. Clin. Invest. 59, 345-359.
5. El-Amin, E. O. (1992). Issues in management of scorpion sting in children. Toxicon 30(1), 111-115.
6. Fraker, P. J., and Speck, J. C. (1978). Protein and cell membrane iodinations with a sparingly soluble chloroamide l,3,4,6-tetrachloro-3o;-6a;-diphenyl-glycoluril. Biochem. Biophys. Res. Commun. 80, 849-857.
7. Gateau, T., Bloom, M., and Clark, R. (1994). Response to spécifie Centruro-ides Sculpturatus antivenom in 151 cases of scorpion stings. Clin. Toxicol. 32(2), 165-171.
8. Gueron, M., Margulis, G., Ilia, R., and Sofer, S. (1993). The management of scorpion envenomation 1993. Toxicon 31(9), 1071-1083.
9. Ismail, M. (1994). The treatment of the scorpion envenoming syndrome: The Saudi experience with serotherapy. Toxicon 32, 1019-1026.
10. Ismail, M., Fatani, F. J. Y., and Debess, T. T. (1992). Experimental treat-ment protocols from scorpion envenomation: A review of common thera-pies and an effect of kallikrein-kinin inhibitors. Toxicon 30, 1257-1279.
11. Ismail, M., Ghazal, A., and El-Fakahany, E. E. (1980). Cardiovascular ef-fects of venom from the scorpion Buthus occitanus Amoreux. Toxicon 18, 327-337.
12. Ismail, M., Shibl, A. M., Morad, A. M., and Abdullah, M. E. (1983). Phar-macokinetics of 1251-labelled antivenin to the venom from the scorpion androctonus amoreuxi. Toxicon 21, 47-56.
13. Johnston, P., Stevenson, I., and Hewick, D. (1987). The influence of digoxin-specific antibody fragments on digoxin disposition in the rat. Biochem. Pharmacol. 36, 2215-2220.
14. Müller, R. (1980). Calculation of average antibody affinity in anti-hapten sera from data obtained by competitive radioimmunoassay. J. Immunol. Methods 34, 345-352.
15. Pentel, P. R., Keyler, D. E., and Brunn, G. J. (1991). Redistribution of tricyclic antidepressants in rats using a drug-specific monoclonal anti-body: Dose-response relationship. Drug Metab. Dispos. 19, 24-28.
16. Pentel, P., Pond, S. M., and Schoof, D. (1987). Redistribution into plasma of tracer doses of desipramine by anti-desipramine antiserum in rats. Biochem. Pharmacol. 36, 293-295.
17. Pepin, S., Lutsch, C., Grandgeorge, M., and Scherrmann, J. M. (1995). Snake F(ab′)2 antivenom from hyperimmunized horse: Pharmacokinetics following intravenous and intramuscular administrations in rabbits. Pharm. Res. 12(10), 1470-1473.
18. Possani, L. D. (1984). Structure of scorpion toxins. In Handbook of Natural Toxins (Tu, A. T., Ed.), Vol. 2, pp. 513-550. Dekker, New York.
19. Sabouraud, A., Urtizberea, M., Cano, N., Grandgeorge, M., Rouzioux, J. M., and Scherrmann, J. M. (1992). Colchicine-specific Fab fragments alter colchicine disposition in rabbits. J. Pharmacol. Exp. Ther. 260, 1214-1219.
20. Salmonson, T., Danielson, B. G., and Wikström, B. (1990). The pharmacokinetics of recombinant human erythropoietin after intravenous and subcutaneous administration to healthy subjects. Br. J. Clin. Pharmac. 29, 709-713.
21. Scherrmann, J. M. (1994). Antibody treatment of toxin poisoning - Recent advances. Clin. Toxicol. 32(4), 363-375.
22. Scherrmann, J. M., Terrien, N., Urtizberea, M., Pierson, P., Denis, H., and Bourre, J. M. (1989). Immunotoxicotherapy: Present status and future trends. J. Toxicol. Clin. Toxicol. 27, 1-35.
23. Sofer, S., Shahak, E., and Gueron, M. (1994). Scorpion envenomation and antivenom therapy. J. Pediatr. 124, 973-978.
24. Waldmann, T. A., Strober, W., and Blaese, R. M. (1970). Variations in the metabolism of immunoglobulins measured by turnover rates. In Immunoglobulins: Biological Aspects and Clinical Uses (E. Merler, Ed.), pp. 33-51. National Academy of Sciences, Washington, DC.
25. Watt, D., and Simard, J. M. (1984). Neurotoxic proteins in scorpion venom. J. Toxicol-Toxin Rev. 3(2 and 3), 181-221.